| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NRI3806 |
| P698 | PubMed publication ID | 25790790 |
| P50 | author | Annette Oxenius | Q87490341 |
| Ulrich Kalinke | Q47156951 | ||
| P2093 | author name string | Josh Crouse | |
| P2860 | cites work | A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus | Q24307721 |
| Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages | Q24642180 | ||
| Interferon-inducible antiviral effectors | Q27486790 | ||
| Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons | Q27671836 | ||
| Virus interference. I. The interferon | Q28181608 | ||
| IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation | Q28207915 | ||
| IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells | Q28214975 | ||
| Mechanisms of type-I- and type-II-interferon-mediated signalling | Q28247893 | ||
| Modulation of human plasmacytoid DC function by IFN-lambda1 (IL-29) | Q28258808 | ||
| Interferons, interferon-like cytokines, and their receptors | Q28293630 | ||
| Type I interferon is required to mount an adaptive response to immunostimulatory DNA | Q28508204 | ||
| Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile | Q28508595 | ||
| Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection | Q28511064 | ||
| Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells | Q28754733 | ||
| Follicular helper CD4 T cells (TFH) | Q29615063 | ||
| Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual | Q30422031 | ||
| Type I interferon is a therapeutic target for virus-induced lethal vascular damage | Q33415686 | ||
| Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection | Q33569835 | ||
| Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection | Q33665625 | ||
| Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population | Q33815694 | ||
| Analysis of apoptosis of memory T cells and dendritic cells during the early stages of viral infection or exposure to toll-like receptor agonists | Q33826847 | ||
| Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses | Q33842424 | ||
| Interferon Induces Natural Killer Cell Blastogenesis In Vivo | Q72728247 | ||
| Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression | Q73092090 | ||
| Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells | Q73189599 | ||
| Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox | Q73956048 | ||
| Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells | Q74587993 | ||
| Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection | Q74813303 | ||
| Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells | Q77303042 | ||
| Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection | Q78346749 | ||
| Down-modulation of responses to type I IFN upon T cell activation | Q78762532 | ||
| Selective Depletion of Nonspecific T Cells During the Early Stage of Immune Responses to Infection | Q79125476 | ||
| Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis | Q80092122 | ||
| IL-12, but not IFN-alpha, promotes STAT4 activation and Th1 development in murine CD4+ T cells expressing a chimeric murine/human Stat2 gene | Q81178259 | ||
| Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation | Q81621807 | ||
| Antigen amount dictates CD8+ T-cell exhaustion during chronic viral infection irrespective of the type of antigen presenting cell | Q84267427 | ||
| Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells | Q42941989 | ||
| IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing. | Q43047480 | ||
| IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells | Q44195895 | ||
| IFN-α exerts opposing effects on activation-induced and IL-7-induced proliferation of T cells that may impair homeostatic maintenance of CD4+ T cell numbers in treated HIV infection | Q44219687 | ||
| Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon | Q44860628 | ||
| Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes | Q45059138 | ||
| Type I IFN substitutes for T cell help during viral infections | Q45309998 | ||
| Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion | Q45373249 | ||
| CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion | Q45418190 | ||
| Effects of IFN-α as a signal-3 cytokine on human naïve and antigen-experienced CD8(+) T cells | Q45865259 | ||
| The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells | Q46071205 | ||
| Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. | Q46315215 | ||
| Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling | Q46465385 | ||
| Sustained IL-12 signaling is required for Th1 development | Q47305582 | ||
| Loss of interferon-induced Stat1 phosphorylation in activated T cells | Q47910671 | ||
| Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo. | Q50982101 | ||
| Signal 3 requirement for memory CD8+ T-cell activation is determined by the infectious pathogen. | Q50996907 | ||
| Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses. | Q51020416 | ||
| Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. | Q51887589 | ||
| Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. | Q51980899 | ||
| IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. | Q51984009 | ||
| Interferon-beta mediates stromal cell rescue of T cells from apoptosis. | Q52034883 | ||
| The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. | Q52181256 | ||
| IFN-alpha2 induces leukocyte integrin redistribution, increased adhesion, and migration. | Q53555608 | ||
| Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. | Q53718320 | ||
| IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis | Q54285337 | ||
| Type I IFNs enhance the terminal differentiation of dendritic cells | Q57272608 | ||
| Antiproliferative action of interferon-α requires components of T-cell-receptor signalling | Q59077517 | ||
| Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-α | Q59415968 | ||
| Expression of CCR-7, MIP-3beta , and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities | Q60687739 | ||
| IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells | Q61268439 | ||
| Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity | Q61316881 | ||
| Type I interferons produced by dendritic cells promote their phenotypic and functional activation | Q61473768 | ||
| Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming | Q63952505 | ||
| Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia | Q63952509 | ||
| Effect of interferon and interferon inducers on the NK sensitivity of normal mouse thymocytes | Q72620737 | ||
| Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes. | Q33862973 | ||
| Natural adjuvants: endogenous activators of dendritic cells | Q33878894 | ||
| Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis | Q33882896 | ||
| Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory | Q33946269 | ||
| T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells | Q33952975 | ||
| Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells | Q34003618 | ||
| Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells | Q34014711 | ||
| Plasmacytoid dendritic cells: recent progress and open questions | Q34162925 | ||
| Out-of-sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses | Q34257444 | ||
| Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses. | Q34345332 | ||
| Differential activity of type I interferon subtypes for dendritic cell differentiation | Q34615006 | ||
| Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion. | Q34845501 | ||
| Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment | Q34857689 | ||
| Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection | Q35018048 | ||
| Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections | Q35034249 | ||
| Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon | Q35077019 | ||
| Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2 | Q35311132 | ||
| Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression | Q35564886 | ||
| IFN-alpha beta and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions | Q35596351 | ||
| Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo | Q35850004 | ||
| Differential role of "Signal 3" inflammatory cytokines in regulating CD8 T cell expansion and differentiation in vivo. | Q35927631 | ||
| Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection | Q35958851 | ||
| Functional STAT3 deficiency compromises the generation of human T follicular helper cells. | Q35970620 | ||
| Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infection | Q35987045 | ||
| Dendritic cells prime natural killer cells by trans-presenting interleukin 15 | Q36157184 | ||
| Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. | Q36191417 | ||
| Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. | Q36228011 | ||
| Stats: multifaceted regulators of transcription | Q36351955 | ||
| Type I interferons keep activated T cells alive | Q36367751 | ||
| Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. | Q36368488 | ||
| Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function | Q36370831 | ||
| Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function | Q36370978 | ||
| Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection | Q36402851 | ||
| Type 1 interferons and the virus-host relationship: a lesson in détente . | Q36475884 | ||
| Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. | Q36547702 | ||
| Type I interferon production in HIV-infected patients | Q36569087 | ||
| Complex modulation of cell type-specific signaling in response to type I interferons | Q36595836 | ||
| Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection | Q36611354 | ||
| Cytokines of the γ(c) family control CD4+ T cell differentiation and function | Q36781465 | ||
| Persistent LCMV infection is controlled by blockade of type I interferon signaling | Q36808119 | ||
| Cutting edge: IL-12 and type I IFN differentially program CD8 T cells for programmed death 1 re-expression levels and tumor control | Q37038661 | ||
| Programming for CD8 T cell memory development requires IL-12 or type I IFN | Q37110371 | ||
| Expanding roles for CD4⁺ T cells in immunity to viruses. | Q37150560 | ||
| High antigen levels are the cause of T cell exhaustion during chronic viral infection | Q37208927 | ||
| TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production | Q37230321 | ||
| Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant | Q37273249 | ||
| Homeostasis of naive and memory T cells | Q37356053 | ||
| Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma | Q37432208 | ||
| Resolution of immune activation defines nonpathogenic SIV infection | Q37432647 | ||
| IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo | Q37483123 | ||
| Type I IFN induces binding of STAT1 to Bcl6: divergent roles of STAT family transcription factors in the T follicular helper cell genetic program | Q37666675 | ||
| Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells | Q37711709 | ||
| Induction of type I IFNs by intracellular DNA-sensing pathways | Q37997334 | ||
| Cross-presentation by dendritic cells | Q38025870 | ||
| Control of human viral infections by natural killer cells | Q38072477 | ||
| Natural killer cells regulate diverse T cell responses. | Q38100373 | ||
| OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids | Q38230646 | ||
| NK cells regulating T cell responses: mechanisms and outcome | Q38272441 | ||
| Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus | Q39439883 | ||
| IFN-α directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity | Q39603416 | ||
| Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) T cells | Q39834545 | ||
| CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs | Q40307375 | ||
| CD8 T Cell Clonal Expansion and Development of Effector Function Require Prolonged Exposure to Antigen, Costimulation, and Signal 3 Cytokine | Q40618314 | ||
| Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells | Q40662596 | ||
| Hypertrophy of infected Peyer's patches arises from global, interferon-receptor, and CD69-independent shutdown of lymphocyte egress | Q40798515 | ||
| Blockade of chronic type I interferon signaling to control persistent LCMV infection | Q41807293 | ||
| Bystander chronic infection negatively impacts development of CD8(+) T cell memory. | Q41809254 | ||
| Type I interferon-mediated stimulation of T cells by CpG DNA | Q41824775 | ||
| Enhanced NK cell activity in mice injected with interferon and interferon inducers | Q41935188 | ||
| Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo | Q41996467 | ||
| Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. | Q42211517 | ||
| Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. | Q42213627 | ||
| Antigen cross-presentation by dendritic cell subsets: one general or all sergeants? | Q42245307 | ||
| Distinct requirements for IFNs and STAT1 in NK cell function | Q42494660 | ||
| IFN-alpha is not sufficient to drive Th1 development due to lack of stable T-bet expression | Q42497613 | ||
| Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing | Q42568916 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 231-242 | |
| P577 | publication date | 2015-03-20 | |
| P1433 | published in | Nature Reviews Immunology | Q43355 |
| P1476 | title | Regulation of antiviral T cell responses by type I interferons | |
| P478 | volume | 15 |
| Q57018017 | "Toll-free" pathways for production of type I interferons |
| Q35969164 | A Computational Model of Inhibition of HIV-1 by Interferon-Alpha |
| Q52603628 | A New In Vivo Model to Study Protective Immunity to Zika Virus Infection in Mice With Intact Type I Interferon Signaling. |
| Q58764812 | A Type I Interferon and IL-10 Induced by Infection Suppresses Antigen-Specific T Cells and Their Memory Responses |
| Q58089560 | Absence of β6 integrin reduces influenza disease severity in highly susceptible obese mice |
| Q63246270 | Advances in mRNA Vaccines for Infectious Diseases |
| Q52680802 | Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses. |
| Q27755387 | Approved Antiviral Drugs over the Past 50 Years |
| Q26767517 | Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza Infection |
| Q95601464 | Baseline pulmonary levels of CD8+ T cells and NK cells inversely correlate with expression of the SARS-CoV-2 entry receptor ACE2 |
| Q40441600 | Blocking Virus Replication during Acute Murine Cytomegalovirus Infection Paradoxically Prolongs Antigen Presentation and Increases the CD8+ T Cell Response by Preventing Type I IFN-Dependent Depletion of Dendritic Cells. |
| Q37545050 | Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs |
| Q45873673 | C-MPL provides tumor-targeted T cell receptor-transgenic T cells with co-stimulation and cytokine signals |
| Q47794110 | Causes of impaired oral vaccine efficacy in developing countries. |
| Q38698679 | Cell Polarization and Epigenetic Status Shape the Heterogeneous Response to Type III Interferons in Intestinal Epithelial Cells. |
| Q40415353 | Cellular response markers and cytokine gene expression in the central nervous system of cattle naturally infected with bovine herpesvirus 5. |
| Q64095697 | Circulating CD56 NK cells inversely correlate with survival of melanoma patients |
| Q58575827 | Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4 T Cell-Independent CD8 T-Cell Response Against Unconjugated Protein Antigen |
| Q88120389 | Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies |
| Q37223530 | Combination of TLR1/2 and TLR3 ligands enhances CD4(+) T cell longevity and antibody responses by modulating type I IFN production. |
| Q59356912 | Combination therapy: A feasibility strategy for CAR-T cell therapy in the treatment of solid tumors |
| Q47952891 | Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant |
| Q91775755 | Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence |
| Q57463606 | Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction |
| Q33425879 | Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection |
| Q37084675 | Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype |
| Q63246454 | Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery |
| Q92062318 | Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes |
| Q91868676 | Dynamic Changes in Natural Killer Cell Subset Frequencies in the Absence of Cytomegalovirus Infection |
| Q64256551 | Emerging Roles of Autophagy and Inflammasome in Ehrlichiosis |
| Q95835388 | Establishment of Murine Infection Models with Biological Clones of Dengue Viruses Derived from a Single Clinical Viral Isolate |
| Q27469006 | Expansion of amphibian intronless interferons revises the paradigm for interferon evolution and functional diversity |
| Q33584106 | Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers |
| Q39028177 | Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML. |
| Q59353254 | Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells |
| Q38788604 | FcγRIIIa Signaling Modulates Endosomal TLR Responses in Human CD4+ T Cells. |
| Q95827278 | Genetic variation in toll like receptors 2, 7, 9 and interleukin-6 is associated with cytomegalovirus infection in late pregnancy |
| Q38511454 | Genetics of systemic sclerosis. |
| Q28086999 | Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors |
| Q40580558 | Herpesvirus-Associated Lymphadenitis Distorts Fibroblastic Reticular Cell Microarchitecture and Attenuates CD8 T Cell Responses to Neurotropic Infection in Mice Lacking the STING-IFNα/β Defense Pathways |
| Q57164156 | Host-pathogen kinetics during influenza infection and coinfection: insights from predictive modeling |
| Q57232542 | Host-pathogen kinetics during influenza infection and coinfection: insights from predictive modeling |
| Q58584193 | Human monocyte-derived macrophages inhibit HCMV spread independent of classical antiviral cytokines |
| Q37321186 | IDO1 and TGF-β Mediate Protective Effects of IFN-α in Antigen-Induced Arthritis |
| Q54966891 | IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway. |
| Q26778206 | IFN-γ Priming Effects on the Maintenance of Effector Memory CD4(+) T Cells and on Phagocyte Function: Evidences from Infectious Diseases |
| Q38486383 | IFNA2: The prototypic human alpha interferon. |
| Q92523911 | IL-27 promotes the expansion of self-renewing CD8+ T cells in persistent viral infection |
| Q40055021 | IRF9 Prevents CD8+ T Cell Exhaustion in an Extrinsic Manner during Acute Lymphocytic Choriomeningitis Virus Infection |
| Q26795372 | Identification of Candidate Predictors of Lupus Flare |
| Q37714302 | Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype |
| Q33797446 | Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C. |
| Q38998931 | Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice |
| Q30398955 | In Vivo and in Vitro Proteome Analysis of Human Immunodeficiency Virus (HIV)-1-infected, Human CD4+ T Cells |
| Q99565633 | In vivo identification of apoptotic and extracellular vesicle-bound live cells using image-based deep learning |
| Q104135062 | Influenza virus neuraminidase regulates host CD8+ T-cell response in mice |
| Q28079141 | Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses |
| Q37592814 | Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy |
| Q37737549 | Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases |
| Q47141979 | Interferon Lambda Genetics and Biology in Regulation of Viral Control |
| Q37670446 | Interferon Lambda: Modulating Immunity in Infectious Diseases |
| Q37224572 | Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function. |
| Q38398206 | Interferons and the Immunogenic Effects of Cancer Therapy |
| Q40065235 | Interleukin-26 Production in Human Primary Bronchial Epithelial Cells in Response to Viral Stimulation: Modulation by Th17 cytokines |
| Q98161951 | Interplay between SARS-CoV-2 and the type I interferon response |
| Q90261882 | Long noncoding RNAs: Novel regulators of virus-host interactions |
| Q36736620 | Membrane Perturbation-Associated Ca2+ Signaling and Incoming Genome Sensing Are Required for the Host Response to Low-Level Enveloped Virus Particle Entry |
| Q37348167 | Modeling the dynamics of neonatal CD8+ T-cell responses |
| Q47563785 | Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response. |
| Q37634675 | Mouse Testicular Cell Type-Specific Antiviral Response against Mumps Virus Replication |
| Q90514963 | Mucosal-associated invariant T cells and Vδ2+ γδ T cells in community acquired pneumonia: association of abundance in sputum with clinical severity and outcome |
| Q90068180 | Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid |
| Q28068695 | Multiple Roles for B-Lymphocytes in Sjogren's Syndrome |
| Q61811446 | Multiplexed enrichment and genomic profiling of peripheral blood cells reveal subset-specific immune signatures |
| Q36499739 | Mumps virus-induced innate immune responses in mouse Sertoli and Leydig cells |
| Q43766620 | MyD88-dependent inflammasome activation and autophagy inhibition contributes to Ehrlichia-induced liver injury and toxic shock |
| Q56993652 | Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation |
| Q90639926 | Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in Mice |
| Q36448944 | OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production |
| Q96683520 | Oncolytic virus-derived type I interferon restricts CAR T cell therapy |
| Q52597633 | Pathogen Recognition by CD4 Effectors Drives Key Effector and Most Memory Cell Generation Against Respiratory Virus. |
| Q64071164 | Priming of HIV-1-specific CD8 T cells with strong functional properties from naïve T cells |
| Q93105617 | Progranulin prevents regulatory NK cell cytotoxicity against antiviral T cells |
| Q55383884 | Report of the inaugural Interferon Research Summit: interferon in inflammatory diseases. |
| Q50130514 | Restoration of the type I IFN-IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in NOD mice. |
| Q99239695 | Robust T cell response towards spike, membrane, and nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients |
| Q93158322 | Shared and Distinct Functions of Type I and Type III Interferons |
| Q94588769 | Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions |
| Q58803374 | Simulation of Stimulation: Cytokine Dosage and Cell Cycle Crosstalk Driving Timing-Dependent T Cell Differentiation |
| Q46608381 | Species-dependent role of type I IFNs and IL-12 in the CTL response induced by humanized CpG complexed with β-glucan |
| Q90017407 | Sustained IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection |
| Q26772138 | The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response |
| Q38860235 | The Roles of Type I Interferon in Bacterial Infection |
| Q106513531 | The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis |
| Q64076929 | The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells |
| Q37065903 | The Type I Interferon-IRF7 Axis Mediates Transcriptional Expression of Usp25 Gene |
| Q26766467 | The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. |
| Q40044627 | The lipid-sensor TREM2 aggravates disease in a model of LCMV-induced hepatitis. |
| Q92355505 | The long noncoding RNA Morrbid regulates CD8 T cells in response to viral infection |
| Q27924714 | The many faces of the flavivirus NS5 protein in antagonism of type I interferon signaling |
| Q39388632 | The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. |
| Q47095345 | Toll-Like Receptor 4, but Not Neutrophil Extracellular Traps, Promote IFN Type I Expression to Enhance Th2 Responses to Nippostrongylus brasiliensis |
| Q40085017 | Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis |
| Q28078725 | Trial Watch-Immunostimulation with cytokines in cancer therapy |
| Q28072347 | Trial Watch-Oncolytic viruses and cancer therapy |
| Q56892924 | Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy |
| Q99552005 | Trial watch: TLR3 agonists in cancer therapy |
| Q40765096 | Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection |
| Q38744710 | Type 1 Interferon in the Human Intestine-A Co-ordinator of the Immune Response to the Microbiota. |
| Q91523108 | Type I IFN Sensing by cDCs and CD4+ T Cell Help Are Both Requisite for Cross-Priming of AAV Capsid-Specific CD8+ T Cells |
| Q41672962 | Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment |
| Q42108741 | Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome |
| Q59352763 | Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression |
| Q91770837 | Type I Interferon Therapy Limits CNS Autoimmunity by Inhibiting CXCR3-Mediated Trafficking of Pathogenic Effector T Cells |
| Q38964752 | Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses |
| Q37691992 | Type I Interferons as Regulators of Lung Inflammation |
| Q106452526 | Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors |
| Q39315038 | Type I interferon pathway in CNS homeostasis and neurological disorders. |
| Q64948180 | Type I interferons in host defence and inflammatory diseases. |
| Q54233818 | Type I interferons in tuberculosis: Foe and occasionally friend. |
| Q36767643 | Type I interferons in viral control and immune regulation |
| Q47557684 | Type I interferons instigate fetal demise after Zika virus infection |
| Q40160105 | Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection |
| Q36445919 | Update on psoriasis immunopathogenesis and targeted immunotherapy. |
| Q57481153 | Viral Encephalitis and Neurologic Diseases: Focus on Astrocytes |
| Q84315417 | Viromimetic STING Agonist‐Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus |
| Q59359933 | Virus-derived immunostimulatory RNA induces type I IFN-dependent antibodies and T-cell responses during vaccination |
| Q26775906 | lncRNAs regulate the innate immune response to viral infection |
Search more.